Equities

Wattanapat Hospital Trang PCL

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Wattanapat Hospital Trang PCL

Actions
Health CareHealth Care Providers
  • Price (THB)6.85
  • Today's Change0.00 / 0.00%
  • Shares traded474.50k
  • 1 Year change-15.69%
  • Beta0.7436
Data delayed at least 15 minutes, as of Feb 16 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Wattanapat Hospital Trang Public Company Limited is a Thailand-based company principally engaged in the hospital business. The Company and its subsidiaries are engaged in providing medical services. The Company is the operator of Wattanapat Hospital Trang, located in Trang province. It operates various clinics, including an obstetrics and gynecology clinic; a surgery clinic; an internal medicine clinic; a children’s clinic; a neurology and brain clinic; a heart clinic; a gastrointestinal and liver clinic; an eye clinic; an ear, nose, and throat clinic; a dental clinic, a health promotion center, and other centers and clinics. Its other centers and clinics include skin and beauty clinics, hyperbaric oxygen therapy, physical therapy, orthopedic clinic, kidney clinic and artificial kidney center, Diabetes, Thyroid and Endocrine Clinic, and others. The Company’s subsidiaries include Wattanapat Ao Nang Hospital Co., Ltd., Wattanapat Samui Hospital Co., Ltd., and Koon Ao Nang Co., Ltd.

  • Revenue in THB (TTM)2.21bn
  • Net income in THB315.89m
  • Incorporated1991
  • Employees533.00
  • Location
    Wattanapat Hospital Trang PCL247/ 2 Phatthalung RoadPhapthiang, MuangBANGKOK 92000ThailandTHA
  • Phone+66 75205555
  • Websitehttps://wattanapat.co.th/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Ladprao General Hospital PCL2.57bn166.40m2.65bn877.0015.921.346.011.030.23110.23113.582.740.848831.367.892,935,026.007.038.138.6710.1426.5726.568.289.571.5010.880.162469.187.438.6923.01-6.68-2.177.57
Ratchaphruek Hospital PCL1.14bn173.40m2.72bn783.0015.401.5810.802.390.32340.32342.123.160.597930.8911.131,454,308.009.1011.649.9013.2533.5037.4515.2319.583.03402.980.002155.53-3.056.62-6.4612.34-26.9515.68
Master Style PCL2.05bn371.17m3.14bn819.008.450.92156.001.531.231.236.7911.290.49418.28159.522,503,143.008.9519.049.8122.6657.4557.4718.1122.500.4225--0.1577--11.3938.8325.5053.5372.52--
Mahachai Hospital PCL6.44bn132.68m3.54bn4.54k26.651.574.270.5490.82930.829340.2514.100.554732.106.431,418,665.001.021.361.542.0318.3221.561.852.910.3861.480.674435.07-0.002321.46-75.13-9.04-33.31-3.58
Nonthavej Hospital PCL2.37bn280.50m3.78bn1.40k13.461.377.961.591.751.7514.8317.180.768333.269.821,696,156.009.0810.5510.0011.6827.1528.7611.8213.244.74--0.0060.360.51741.94-6.96-3.0217.24-2.81
Rajthanee Hospital PCL2.64bn252.58m3.87bn1.33k15.021.829.081.460.85910.85918.987.100.615431.965.321,982,343.005.5220.887.6229.5222.1538.118.9725.040.59465.230.380972.0316.649.1117.484.4922.86-8.64
Patrangsit Healthcare Group PCL2.44bn304.05m3.93bn1.55k12.931.839.661.611.011.018.137.160.995427.497.561,578,876.0012.4114.2914.2817.8124.6426.6612.4612.324.62743.660.0034--6.329.54-2.7933.20-17.14--
Ekachai Medical Care PCL1.21bn243.43m4.32bn588.0016.531.7612.883.570.30550.30551.512.860.442419.4810.632,060,954.009.1416.9010.7619.1441.6943.1120.6728.934.58--0.031470.998.138.08-5.7911.812.2423.40
Wattanapat Hospital Trang PCL2.21bn315.89m4.80bn533.0014.812.638.152.170.46250.46253.212.610.719528.0110.144,149,617.0010.496.8812.288.1832.0228.3814.5710.680.878810.630.378130.3839.2321.92200.13--12.08-47.68
Klinique Medical Clinic PCL3.39bn351.56m5.32bn1.34k15.143.207.771.571.601.6015.397.561.105.4961.042,536,535.0011.4612.2116.4318.6751.2154.7910.4012.310.881831.560.283--30.5625.0411.6322.7833.53--
Srivichai Vejvivat PCL2.98bn394.63m5.44bn1.81k13.581.459.381.820.6480.6484.906.050.718940.855.701,651,977.009.5416.7110.6720.3726.7632.2813.2716.974.121,339.770.018332.152.792.5210.759.496.2012.30
Chiang Mai Ram Medical Business PCL5.09bn-66.58m5.74bn1.46k--1.9115.731.13-0.0164-0.01641.250.73920.473332.779.033,492,063.00-0.90153.17-1.805.6418.4723.46-1.908.230.38482.130.442286.694.396.13-40.07-3.76-23.47-3.09
Thai Nakarin Hospital PCL2.76bn378.85m5.81bn1.16k15.321.6911.432.102.102.1015.3219.110.715546.4412.29--9.8312.4011.0413.9625.7727.3513.7415.195.09--0.000527.492.386.64-9.239.0231.035.92
Principal Capital PCL5.86bn-535.52m6.93bn4.05k--0.78988.931.18-0.1406-0.14061.542.310.384336.538.971,448,594.00-3.90-1.79-4.63-2.2018.3722.85-10.14-5.910.5538-1.580.2936--12.2414.7141.67--1.33--
Data as of Feb 16 2026. Currency figures normalised to Wattanapat Hospital Trang PCL's reporting currency: Thai Baht THB

Institutional shareholders

0.02%Per cent of shares held by top holders
HolderShares% Held
Bangkok Capital Asset Management Co. Ltd.as of 30 Sep 2025168.58k0.02%
SCB Asset Management Co., Ltd.as of 30 Sep 20250.000.00%
Krung Thai Asset Management Public Co., Ltd.as of 30 Sep 20250.000.00%
Data from 30 Sep 2025 - 30 Sep 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.